AU726892B2 - Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof - Google Patents

Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof Download PDF

Info

Publication number: AU726892B2
Authority: AU; Australia
Prior art keywords: seq; pylori; polypeptide; fragment; amino acid
Prior art date: 1996-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

AU25984/97A

Other languages

English (en)

Other versions

AU2598497A (en

Inventor

Richard A. Alm

Douglas Smith

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

Astra AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-29

Filing date

1997-03-27

Publication date

2000-11-23

1997-03-27 Application filed by Astra AB filed Critical Astra AB

1997-10-22 Publication of AU2598497A publication Critical patent/AU2598497A/en

2000-11-23 Application granted granted Critical

2000-11-23 Publication of AU726892B2 publication Critical patent/AU726892B2/en

2017-03-27 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims description 257
108020004707 nucleic acids Proteins 0.000 title claims description 254
102000039446 nucleic acids Human genes 0.000 title claims description 254
125000003275 alpha amino acid group Chemical group 0.000 title claims description 120
239000000203 mixture Substances 0.000 title claims description 30
229960005486 vaccine Drugs 0.000 title description 38
241000590002 Helicobacter pylori Species 0.000 title description 15
229940037467 helicobacter pylori Drugs 0.000 title description 14
108090000765 processed proteins & peptides Proteins 0.000 claims description 624
102000004196 processed proteins & peptides Human genes 0.000 claims description 574
229920001184 polypeptide Polymers 0.000 claims description 534
239000012634 fragment Substances 0.000 claims description 240
210000004027 cell Anatomy 0.000 claims description 162
239000002773 nucleotide Substances 0.000 claims description 119
125000003729 nucleotide group Chemical group 0.000 claims description 119
238000000034 method Methods 0.000 claims description 104
239000012528 membrane Substances 0.000 claims description 90
230000014509 gene expression Effects 0.000 claims description 79
238000006243 chemical reaction Methods 0.000 claims description 55
238000003556 assay Methods 0.000 claims description 39
150000001413 amino acids Chemical class 0.000 claims description 38
239000000523 sample Substances 0.000 claims description 38
241000588724 Escherichia coli Species 0.000 claims description 36
230000001086 cytosolic effect Effects 0.000 claims description 34
238000012360 testing method Methods 0.000 claims description 32
230000002163 immunogen Effects 0.000 claims description 28
241000894006 Bacteria Species 0.000 claims description 27
102000009016 Cholera Toxin Human genes 0.000 claims description 26
108010049048 Cholera Toxin Proteins 0.000 claims description 26
230000001580 bacterial effect Effects 0.000 claims description 25
150000001875 compounds Chemical class 0.000 claims description 25
239000000126 substance Substances 0.000 claims description 24
230000032258 transport Effects 0.000 claims description 22
239000013604 expression vector Substances 0.000 claims description 21
241000589989 Helicobacter Species 0.000 claims description 16
230000004060 metabolic process Effects 0.000 claims description 16
230000028327 secretion Effects 0.000 claims description 15
238000011282 treatment Methods 0.000 claims description 15
210000004899 c-terminal region Anatomy 0.000 claims description 14
230000001225 therapeutic effect Effects 0.000 claims description 14
230000035897 transcription Effects 0.000 claims description 14
238000013518 transcription Methods 0.000 claims description 14
239000002671 adjuvant Substances 0.000 claims description 12
239000002245 particle Substances 0.000 claims description 12
COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 12
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 12
238000004519 manufacturing process Methods 0.000 claims description 11
230000001413 cellular effect Effects 0.000 claims description 10
239000003937 drug carrier Substances 0.000 claims description 10
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 10
230000000295 complement effect Effects 0.000 claims description 9
238000001514 detection method Methods 0.000 claims description 7
230000010076 replication Effects 0.000 claims description 7
230000004260 plant-type cell wall biogenesis Effects 0.000 claims description 6
230000001105 regulatory effect Effects 0.000 claims description 6
241000700605 Viruses Species 0.000 claims description 5
230000037354 amino acid metabolism Effects 0.000 claims description 5
230000037356 lipid metabolism Effects 0.000 claims description 5
230000037360 nucleotide metabolism Effects 0.000 claims description 5
230000006798 recombination Effects 0.000 claims description 5
238000005215 recombination Methods 0.000 claims description 5
230000008439 repair process Effects 0.000 claims description 5
238000007423 screening assay Methods 0.000 claims description 5
230000002238 attenuated effect Effects 0.000 claims description 4
239000002502 liposome Substances 0.000 claims description 4
239000006166 lysate Substances 0.000 claims description 4
239000003094 microcapsule Substances 0.000 claims description 4
BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims description 4
238000003259 recombinant expression Methods 0.000 claims description 4
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims description 2
238000012258 culturing Methods 0.000 claims description 2
230000002538 fungal effect Effects 0.000 claims description 2
150000004676 glycans Chemical class 0.000 claims description 2
231100000252 nontoxic Toxicity 0.000 claims description 2
230000003000 nontoxic effect Effects 0.000 claims description 2
229920000642 polymer Polymers 0.000 claims description 2
229920001282 polysaccharide Polymers 0.000 claims description 2
239000005017 polysaccharide Substances 0.000 claims description 2
229930182490 saponin Natural products 0.000 claims description 2
150000007949 saponins Chemical class 0.000 claims description 2
239000003053 toxin Substances 0.000 claims description 2
231100000765 toxin Toxicity 0.000 claims description 2
206010019375 Helicobacter infections Diseases 0.000 claims 2
238000011321 prophylaxis Methods 0.000 claims 2
QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 claims 1
150000002148 esters Chemical class 0.000 claims 1
QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 claims 1
239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 355
102000004169 proteins and genes Human genes 0.000 description 207
235000018102 proteins Nutrition 0.000 description 202
108020004414 DNA Proteins 0.000 description 161
108700026244 Open Reading Frames Proteins 0.000 description 91
238000003752 polymerase chain reaction Methods 0.000 description 78
239000000047 product Substances 0.000 description 67
210000004379 membrane Anatomy 0.000 description 65
239000013615 primer Substances 0.000 description 60
239000013612 plasmid Substances 0.000 description 55
238000010367 cloning Methods 0.000 description 54
239000013598 vector Substances 0.000 description 49
108091028043 Nucleic acid sequence Proteins 0.000 description 47
230000000694 effects Effects 0.000 description 44
235000001014 amino acid Nutrition 0.000 description 38
208000015181 infectious disease Diseases 0.000 description 36
108091007433 antigens Proteins 0.000 description 35
102000036639 antigens Human genes 0.000 description 35
229940024606 amino acid Drugs 0.000 description 34
108091034117 Oligonucleotide Proteins 0.000 description 32
-1 Orn Chemical compound 0.000 description 31
239000000427 antigen Substances 0.000 description 31
238000002360 preparation method Methods 0.000 description 31
238000000746 purification Methods 0.000 description 28
230000027455 binding Effects 0.000 description 27
229930027917 kanamycin Natural products 0.000 description 26
229960000318 kanamycin Drugs 0.000 description 26
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 26
229930182823 kanamycin A Natural products 0.000 description 26
238000009396 hybridization Methods 0.000 description 23
241001465754 Metazoa Species 0.000 description 22
238000012163 sequencing technique Methods 0.000 description 22
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
108010052285 Membrane Proteins Proteins 0.000 description 21
238000004925 denaturation Methods 0.000 description 20
230000036425 denaturation Effects 0.000 description 20
230000003053 immunization Effects 0.000 description 20
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 19
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 19
230000004927 fusion Effects 0.000 description 19
230000014616 translation Effects 0.000 description 19
238000012408 PCR amplification Methods 0.000 description 18
230000003321 amplification Effects 0.000 description 18
238000002649 immunization Methods 0.000 description 18
238000003199 nucleic acid amplification method Methods 0.000 description 18
108020004705 Codon Proteins 0.000 description 17
125000000539 amino acid group Chemical group 0.000 description 17
239000003599 detergent Substances 0.000 description 16
238000000338 in vitro Methods 0.000 description 16
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 16
238000012216 screening Methods 0.000 description 16
102000004190 Enzymes Human genes 0.000 description 15
108090000790 Enzymes Proteins 0.000 description 15
108010020062 Peptidylprolyl Isomerase Proteins 0.000 description 15
102000009658 Peptidylprolyl Isomerase Human genes 0.000 description 15
230000004071 biological effect Effects 0.000 description 15
229940088598 enzyme Drugs 0.000 description 15
239000003446 ligand Substances 0.000 description 15
238000013519 translation Methods 0.000 description 15
102000018697 Membrane Proteins Human genes 0.000 description 14
230000006870 function Effects 0.000 description 14
238000006467 substitution reaction Methods 0.000 description 14
108091026890 Coding region Proteins 0.000 description 13
210000001744 T-lymphocyte Anatomy 0.000 description 13
238000004458 analytical method Methods 0.000 description 13
230000029087 digestion Effects 0.000 description 13
102000037865 fusion proteins Human genes 0.000 description 13
108020001507 fusion proteins Proteins 0.000 description 13
230000004048 modification Effects 0.000 description 13
238000012986 modification Methods 0.000 description 13
238000002703 mutagenesis Methods 0.000 description 13
231100000350 mutagenesis Toxicity 0.000 description 13
230000035772 mutation Effects 0.000 description 13
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
239000003814 drug Substances 0.000 description 12
108020004999 messenger RNA Proteins 0.000 description 12
FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
239000011543 agarose gel Substances 0.000 description 11
230000000692 anti-sense effect Effects 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
239000003153 chemical reaction reagent Substances 0.000 description 11
239000000499 gel Substances 0.000 description 11
230000002441 reversible effect Effects 0.000 description 11
238000003786 synthesis reaction Methods 0.000 description 11
230000009466 transformation Effects 0.000 description 11
241000699666 Mus <mouse, genus> Species 0.000 description 10
241000699670 Mus sp. Species 0.000 description 10
239000007983 Tris buffer Substances 0.000 description 10
239000000872 buffer Substances 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
238000012217 deletion Methods 0.000 description 10
230000037430 deletion Effects 0.000 description 10
210000002966 serum Anatomy 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 10
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
241000589562 Brucella Species 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
101710116435 Outer membrane protein Proteins 0.000 description 9
108020004511 Recombinant DNA Proteins 0.000 description 9
238000013459 approach Methods 0.000 description 9
239000012139 lysis buffer Substances 0.000 description 9
239000008188 pellet Substances 0.000 description 9
238000005382 thermal cycling Methods 0.000 description 9
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 8
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 8
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
101710137500 T7 RNA polymerase Proteins 0.000 description 8
230000004075 alteration Effects 0.000 description 8
229960000723 ampicillin Drugs 0.000 description 8
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
238000002744 homologous recombination Methods 0.000 description 8
230000006801 homologous recombination Effects 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
244000052769 pathogen Species 0.000 description 8
101150010516 ppi gene Proteins 0.000 description 8
101150105899 ppiB gene Proteins 0.000 description 8
108091008146 restriction endonucleases Proteins 0.000 description 8
238000010561 standard procedure Methods 0.000 description 8
239000000725 suspension Substances 0.000 description 8
NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 7
239000003155 DNA primer Substances 0.000 description 7
238000001712 DNA sequencing Methods 0.000 description 7
230000002759 chromosomal effect Effects 0.000 description 7
108010048032 cyclophilin B Proteins 0.000 description 7
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 7
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 7
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 7
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 7
229940009976 deoxycholate Drugs 0.000 description 7
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 7
238000011161 development Methods 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
239000013613 expression plasmid Substances 0.000 description 7
239000002609 medium Substances 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
108700016167 Glutamate racemases Proteins 0.000 description 6
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 6
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
108091006629 SLC13A2 Proteins 0.000 description 6
108091081024 Start codon Proteins 0.000 description 6
238000007792 addition Methods 0.000 description 6
229940098773 bovine serum albumin Drugs 0.000 description 6
229940041514 candida albicans extract Drugs 0.000 description 6
239000004202 carbamide Substances 0.000 description 6
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 6
229940079593 drug Drugs 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
238000005516 engineering process Methods 0.000 description 6
230000002255 enzymatic effect Effects 0.000 description 6
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 6
229960005542 ethidium bromide Drugs 0.000 description 6
239000000284 extract Substances 0.000 description 6
230000002068 genetic effect Effects 0.000 description 6
230000002209 hydrophobic effect Effects 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
230000028993 immune response Effects 0.000 description 6
230000001965 increasing effect Effects 0.000 description 6
238000011534 incubation Methods 0.000 description 6
238000002955 isolation Methods 0.000 description 6
230000001404 mediated effect Effects 0.000 description 6
210000002729 polyribosome Anatomy 0.000 description 6
102000005962 receptors Human genes 0.000 description 6
108020003175 receptors Proteins 0.000 description 6
230000009467 reduction Effects 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
210000002784 stomach Anatomy 0.000 description 6
239000012137 tryptone Substances 0.000 description 6
230000003612 virological effect Effects 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
239000012138 yeast extract Substances 0.000 description 6
AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 description 5
WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 5
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 5
KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 description 5
230000006820 DNA synthesis Effects 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
239000007995 HEPES buffer Substances 0.000 description 5
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 5
108010076504 Protein Sorting Signals Proteins 0.000 description 5
108010001267 Protein Subunits Proteins 0.000 description 5
102000002067 Protein Subunits Human genes 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
238000012300 Sequence Analysis Methods 0.000 description 5
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 5
108700019146 Transgenes Proteins 0.000 description 5
239000002253 acid Substances 0.000 description 5
230000000890 antigenic effect Effects 0.000 description 5
239000006161 blood agar Substances 0.000 description 5
230000008859 change Effects 0.000 description 5
238000010276 construction Methods 0.000 description 5
238000013461 design Methods 0.000 description 5
239000008103 glucose Substances 0.000 description 5
230000001771 impaired effect Effects 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 5
229960002064 kanamycin sulfate Drugs 0.000 description 5
210000004962 mammalian cell Anatomy 0.000 description 5
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
238000012545 processing Methods 0.000 description 5
125000006853 reporter group Chemical group 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
239000001226 triphosphate Substances 0.000 description 5
235000011178 triphosphate Nutrition 0.000 description 5
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 5
241001515965 unidentified phage Species 0.000 description 5
230000001018 virulence Effects 0.000 description 5
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 4
101710132601 Capsid protein Proteins 0.000 description 4
101710094648 Coat protein Proteins 0.000 description 4
DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 description 4
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 4
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 4
ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 4
AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 description 4
102000012410 DNA Ligases Human genes 0.000 description 4
108010061982 DNA Ligases Proteins 0.000 description 4
241000724791 Filamentous phage Species 0.000 description 4
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 4
241000238631 Hexapoda Species 0.000 description 4
102100034349 Integrase Human genes 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
101710125418 Major capsid protein Proteins 0.000 description 4
102000016943 Muramidase Human genes 0.000 description 4
108010014251 Muramidase Proteins 0.000 description 4
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 4
101710141454 Nucleoprotein Proteins 0.000 description 4
239000002033 PVDF binder Substances 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
101710083689 Probable capsid protein Proteins 0.000 description 4
108010046334 Urease Proteins 0.000 description 4
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
235000004279 alanine Nutrition 0.000 description 4
238000012867 alanine scanning Methods 0.000 description 4
239000005557 antagonist Substances 0.000 description 4
229910002091 carbon monoxide Inorganic materials 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
210000004978 chinese hamster ovary cell Anatomy 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
238000000502 dialysis Methods 0.000 description 4
238000009826 distribution Methods 0.000 description 4
230000008029 eradication Effects 0.000 description 4
230000001747 exhibiting effect Effects 0.000 description 4
238000009472 formulation Methods 0.000 description 4
230000002496 gastric effect Effects 0.000 description 4
230000012010 growth Effects 0.000 description 4
230000001976 improved effect Effects 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
229960000274 lysozyme Drugs 0.000 description 4
239000004325 lysozyme Substances 0.000 description 4
235000010335 lysozyme Nutrition 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
238000002156 mixing Methods 0.000 description 4
238000002823 phage display Methods 0.000 description 4
229920002401 polyacrylamide Polymers 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
229920002981 polyvinylidene fluoride Polymers 0.000 description 4
239000002987 primer (paints) Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
230000007017 scission Effects 0.000 description 4
238000007790 scraping Methods 0.000 description 4
241000894007 species Species 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
229940124597 therapeutic agent Drugs 0.000 description 4
230000002103 transcriptional effect Effects 0.000 description 4
238000012546 transfer Methods 0.000 description 4
230000009261 transgenic effect Effects 0.000 description 4
GHKCSRZBNZQHKW-UHFFFAOYSA-N 1-sulfanylethanol Chemical compound CC(O)S GHKCSRZBNZQHKW-UHFFFAOYSA-N 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
101150029029 CAVIN4 gene Proteins 0.000 description 3
102100035882 Catalase Human genes 0.000 description 3
108010053835 Catalase Proteins 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
108090000695 Cytokines Proteins 0.000 description 3
XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
101710091045 Envelope protein Proteins 0.000 description 3
244000068988 Glycine max Species 0.000 description 3
235000010469 Glycine max Nutrition 0.000 description 3
241000282412 Homo Species 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
101710203526 Integrase Proteins 0.000 description 3
102000000588 Interleukin-2 Human genes 0.000 description 3
108010002350 Interleukin-2 Proteins 0.000 description 3
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
235000019687 Lamb Nutrition 0.000 description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
239000006142 Luria-Bertani Agar Substances 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000004677 Nylon Substances 0.000 description 3
WXOMTJVVIMOXJL-BOBFKVMVSA-A O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O WXOMTJVVIMOXJL-BOBFKVMVSA-A 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
102000035195 Peptidases Human genes 0.000 description 3
239000004365 Protease Substances 0.000 description 3
101710188315 Protein X Proteins 0.000 description 3
101000697856 Rattus norvegicus Bile acid-CoA:amino acid N-acyltransferase Proteins 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
230000006052 T cell proliferation Effects 0.000 description 3
239000004473 Threonine Substances 0.000 description 3
229940122618 Trypsin inhibitor Drugs 0.000 description 3
101710162629 Trypsin inhibitor Proteins 0.000 description 3
239000000556 agonist Substances 0.000 description 3
NWMHDZMRVUOQGL-CZEIJOLGSA-N almurtide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)CO[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O NWMHDZMRVUOQGL-CZEIJOLGSA-N 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
239000006143 cell culture medium Substances 0.000 description 3
239000013599 cloning vector Substances 0.000 description 3
238000002742 combinatorial mutagenesis Methods 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
239000000975 dye Substances 0.000 description 3
238000004520 electroporation Methods 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
230000010354 integration Effects 0.000 description 3
101150066555 lacZ gene Proteins 0.000 description 3
235000005772 leucine Nutrition 0.000 description 3
239000007788 liquid Substances 0.000 description 3
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
229920001778 nylon Polymers 0.000 description 3
238000010647 peptide synthesis reaction Methods 0.000 description 3
238000007747 plating Methods 0.000 description 3
239000013641 positive control Substances 0.000 description 3
230000001915 proofreading effect Effects 0.000 description 3
230000000069 prophylactic effect Effects 0.000 description 3
235000019419 proteases Nutrition 0.000 description 3
229940126409 proton pump inhibitor Drugs 0.000 description 3
235000021251 pulses Nutrition 0.000 description 3
238000002708 random mutagenesis Methods 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
235000004400 serine Nutrition 0.000 description 3
235000019333 sodium laurylsulphate Nutrition 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
235000008521 threonine Nutrition 0.000 description 3
230000001131 transforming effect Effects 0.000 description 3
239000003656 tris buffered saline Substances 0.000 description 3
239000002753 trypsin inhibitor Substances 0.000 description 3
238000003160 two-hybrid assay Methods 0.000 description 3
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
239000004474 valine Substances 0.000 description 3
230000035899 viability Effects 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
108010039627 Aprotinin Proteins 0.000 description 2
101100234243 Aquifex aeolicus (strain VF5) kdtA gene Proteins 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
238000011725 BALB/c mouse Methods 0.000 description 2
102100026189 Beta-galactosidase Human genes 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 description 2
ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 2
MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
150000008574 D-amino acids Chemical class 0.000 description 2
ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 2
HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 2
KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 2
230000004543 DNA replication Effects 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
102000004533 Endonucleases Human genes 0.000 description 2
101100322888 Escherichia coli (strain K12) metL gene Proteins 0.000 description 2
241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
241001646716 Escherichia coli K-12 Species 0.000 description 2
108700039887 Essential Genes Proteins 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
101001066288 Gallus gallus GATA-binding factor 3 Proteins 0.000 description 2
108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
108010070675 Glutathione transferase Proteins 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
QEFRNWWLZKMPFJ-YGVKFDHGSA-N L-methionine S-oxide Chemical compound CS(=O)CC[C@H](N)C(O)=O QEFRNWWLZKMPFJ-YGVKFDHGSA-N 0.000 description 2
239000006137 Luria-Bertani broth Substances 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
241000202946 Mycoplasma pulmonis Species 0.000 description 2
108700015872 N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine Proteins 0.000 description 2
MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
102000010562 Peptide Elongation Factor G Human genes 0.000 description 2
108010077742 Peptide Elongation Factor G Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
101800001440 Rimorphin Proteins 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
101100443856 Streptococcus pyogenes serotype M18 (strain MGAS8232) polC gene Proteins 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
108091008874 T cell receptors Proteins 0.000 description 2
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
239000006180 TBST buffer Substances 0.000 description 2
102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 2
108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000009471 action Effects 0.000 description 2
239000012190 activator Substances 0.000 description 2
230000010933 acylation Effects 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000007815 allergy Effects 0.000 description 2
230000030741 antigen processing and presentation Effects 0.000 description 2
210000000612 antigen-presenting cell Anatomy 0.000 description 2
229960004405 aprotinin Drugs 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
230000037429 base substitution Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000002775 capsule Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000012219 cassette mutagenesis Methods 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
230000032823 cell division Effects 0.000 description 2
230000003915 cell function Effects 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000013522 chelant Substances 0.000 description 2
150000005829 chemical entities Chemical class 0.000 description 2
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
230000005757 colony formation Effects 0.000 description 2
239000000287 crude extract Substances 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
101150076598 dnaB gene Proteins 0.000 description 2
101150008507 dnaE gene Proteins 0.000 description 2
101150035285 dnaE1 gene Proteins 0.000 description 2
101150003155 dnaG gene Proteins 0.000 description 2
238000007878 drug screening assay Methods 0.000 description 2
208000000718 duodenal ulcer Diseases 0.000 description 2
210000003495 flagella Anatomy 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
229960002989 glutamic acid Drugs 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000012203 high throughput assay Methods 0.000 description 2
230000008348 humoral response Effects 0.000 description 2
125000001165 hydrophobic group Chemical group 0.000 description 2
238000003119 immunoblot Methods 0.000 description 2
210000003000 inclusion body Anatomy 0.000 description 2
230000006698 induction Effects 0.000 description 2
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
230000004068 intracellular signaling Effects 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
238000006317 isomerization reaction Methods 0.000 description 2
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
101150109249 lacI gene Proteins 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
235000019341 magnesium sulphate Nutrition 0.000 description 2
239000003550 marker Substances 0.000 description 2
229910021645 metal ion Inorganic materials 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
210000003097 mucus Anatomy 0.000 description 2
YFCUZWYIPBUQBD-ZOWNYOTGSA-N n-[(3s)-7-amino-1-chloro-2-oxoheptan-3-yl]-4-methylbenzenesulfonamide;hydron;chloride Chemical compound Cl.CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 YFCUZWYIPBUQBD-ZOWNYOTGSA-N 0.000 description 2
238000002663 nebulization Methods 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229940079938 nitrocellulose Drugs 0.000 description 2
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 2
SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 2
229960000381 omeprazole Drugs 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
238000004091 panning Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000037361 pathway Effects 0.000 description 2
FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 2
239000000816 peptidomimetic Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
230000026731 phosphorylation Effects 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
238000013492 plasmid preparation Methods 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
238000001742 protein purification Methods 0.000 description 2
238000001243 protein synthesis Methods 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
230000009711 regulatory function Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
238000002864 sequence alignment Methods 0.000 description 2
229940083575 sodium dodecyl sulfate Drugs 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
230000003381 solubilizing effect Effects 0.000 description 2
238000000527 sonication Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
230000009897 systematic effect Effects 0.000 description 2
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000000844 transformation Methods 0.000 description 2
108091005703 transmembrane proteins Proteins 0.000 description 2
102000035160 transmembrane proteins Human genes 0.000 description 2
241000701447 unidentified baculovirus Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
229940125575 vaccine candidate Drugs 0.000 description 2
101150040194 waaA gene Proteins 0.000 description 2
238000005406 washing Methods 0.000 description 2
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
XSYUPRQVAHJETO-WPMUBMLPSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidaz Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 XSYUPRQVAHJETO-WPMUBMLPSA-N 0.000 description 1
AGTSSZRZBSNTGQ-ITZCFHCWSA-N (2s,3r)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomet Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 AGTSSZRZBSNTGQ-ITZCFHCWSA-N 0.000 description 1
YHQZWWDVLJPRIF-JLHRHDQISA-N (4R)-4-[[(2S,3R)-2-[acetyl-[(3R,4R,5S,6R)-3-amino-4-[(1R)-1-carboxyethoxy]-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid Chemical compound C(C)(=O)N([C@@H]([C@H](O)C)C(=O)N[C@H](CCC(=O)O)C(N)=O)C1[C@H](N)[C@@H](O[C@@H](C(=O)O)C)[C@H](O)[C@H](O1)CO YHQZWWDVLJPRIF-JLHRHDQISA-N 0.000 description 1
QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 description 1
CJAOGUFAAWZWNI-UHFFFAOYSA-N 1-n,1-n,4-n,4-n-tetramethylbenzene-1,4-diamine Chemical compound CN(C)C1=CC=C(N(C)C)C=C1 CJAOGUFAAWZWNI-UHFFFAOYSA-N 0.000 description 1
SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
238000010600 3H thymidine incorporation assay Methods 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 1
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
101100165658 Alternaria brassicicola bsc5 gene Proteins 0.000 description 1
244000153158 Ammi visnaga Species 0.000 description 1
235000010585 Ammi visnaga Nutrition 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
244000105975 Antidesma platyphyllum Species 0.000 description 1
101100032924 Bacillus subtilis (strain 168) radA gene Proteins 0.000 description 1
231100000699 Bacterial toxin Toxicity 0.000 description 1
101000609456 Beet necrotic yellow vein virus (isolate Japan/S) Protein P26 Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
101100227322 Caenorhabditis elegans fli-1 gene Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000589876 Campylobacter Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000003846 Carbonic anhydrases Human genes 0.000 description 1
108090000209 Carbonic anhydrases Proteins 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102000005600 Cathepsins Human genes 0.000 description 1
108010084457 Cathepsins Proteins 0.000 description 1
108010039939 Cell Wall Skeleton Proteins 0.000 description 1
102000003813 Cis-trans-isomerases Human genes 0.000 description 1
108090000175 Cis-trans-isomerases Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
101100423897 Clostridium perfringens (strain 13 / Type A) glnS gene Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 1
PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 1
108010068682 Cyclophilins Proteins 0.000 description 1
102000001493 Cyclophilins Human genes 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
229930182847 D-glutamic acid Natural products 0.000 description 1
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
102100024607 DNA topoisomerase 1 Human genes 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
101100492392 Didymella fabae pksAC gene Proteins 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
101100108073 Drosophila melanogaster Actn gene Proteins 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
108010013369 Enteropeptidase Proteins 0.000 description 1
102100029727 Enteropeptidase Human genes 0.000 description 1
101100012780 Escherichia coli (strain K12) fecA gene Proteins 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010000916 Fimbriae Proteins Proteins 0.000 description 1
108010040721 Flagellin Proteins 0.000 description 1
241000589599 Francisella tularensis subsp. novicida Species 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
208000007882 Gastritis Diseases 0.000 description 1
238000003794 Gram staining Methods 0.000 description 1
241000606768 Haemophilus influenzae Species 0.000 description 1
241001674326 Helicobacter pylori J99 Species 0.000 description 1
108010093488 His-His-His-His-His-His Proteins 0.000 description 1
101000830681 Homo sapiens DNA topoisomerase 1 Proteins 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000004388 Interleukin-4 Human genes 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
LFZGUGJDVUUGLK-REOHCLBHSA-N L-serine O-sulfate Chemical compound OC(=O)[C@@H](N)COS(O)(=O)=O LFZGUGJDVUUGLK-REOHCLBHSA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
101710105045 Lipoprotein E Proteins 0.000 description 1
239000004425 Makrolon Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
241000353097 Molva molva Species 0.000 description 1
206010065764 Mucosal infection Diseases 0.000 description 1
101100281205 Mus musculus Fli1 gene Proteins 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
108700020354 N-acetylmuramyl-threonyl-isoglutamine Proteins 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
206010034133 Pathogen resistance Diseases 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010071384 Peptide T Proteins 0.000 description 1
101100226893 Phomopsis amygdali PaP450-2 gene Proteins 0.000 description 1
108010065081 Phosphorylase b Proteins 0.000 description 1
235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
101710118538 Protease Proteins 0.000 description 1
102100037681 Protein FEV Human genes 0.000 description 1
101710198166 Protein FEV Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
238000012181 QIAquick gel extraction kit Methods 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102400000235 Rimorphin Human genes 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
108091006627 SLC12A9 Proteins 0.000 description 1
229920002305 Schizophyllan Polymers 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
101900014382 Staphylococcus haemolyticus Glutamate racemase Proteins 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
241000192560 Synechococcus sp. Species 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
241000255588 Tephritidae Species 0.000 description 1
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
238000003314 affinity selection Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
239000013566 allergen Substances 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
108010013829 alpha subunit DNA polymerase III Proteins 0.000 description 1
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002788 anti-peptide Effects 0.000 description 1
229940124350 antibacterial drug Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
238000011203 antimicrobial therapy Methods 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
238000002820 assay format Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000000688 bacterial toxin Substances 0.000 description 1
239000011324 bead Substances 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
208000003836 bluetongue Diseases 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
210000004520 cell wall skeleton Anatomy 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000008614 cellular interaction Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
230000007541 cellular toxicity Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
238000012412 chemical coupling Methods 0.000 description 1
238000002144 chemical decomposition reaction Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
208000023652 chronic gastritis Diseases 0.000 description 1
238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
238000000975 co-precipitation Methods 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000004940 costimulation Effects 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000009513 drug distribution Methods 0.000 description 1
238000007877 drug screening Methods 0.000 description 1
239000003596 drug target Substances 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
201000006549 dyspepsia Diseases 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
235000014103 egg white Nutrition 0.000 description 1
210000000969 egg white Anatomy 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
244000088681 endo Species 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000000688 enterotoxigenic effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000001400 expression cloning Methods 0.000 description 1
235000013861 fat-free Nutrition 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
101150017109 fliA gene Proteins 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000005021 gait Effects 0.000 description 1
210000004211 gastric acid Anatomy 0.000 description 1
201000006585 gastric adenocarcinoma Diseases 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
201000005917 gastric ulcer Diseases 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
238000012248 genetic selection Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
101150103988 gltX gene Proteins 0.000 description 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
239000011544 gradient gel Substances 0.000 description 1
101150077981 groEL gene Proteins 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
235000009424 haa Nutrition 0.000 description 1
230000036541 health Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000002443 helper t lymphocyte Anatomy 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000012606 in vitro cell culture Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000003999 initiator Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
239000000138 intercalating agent Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229940028885 interleukin-4 Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
VAVAILGEOMLRRK-UHFFFAOYSA-H iron(III) dicitrate(3-) Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VAVAILGEOMLRRK-UHFFFAOYSA-H 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
150000003951 lactams Chemical group 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000002523 lectin Substances 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
238000007169 ligase reaction Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
238000011068 loading method Methods 0.000 description 1
101150103033 lpxB gene Proteins 0.000 description 1
101150033242 lpxC gene Proteins 0.000 description 1
239000000891 luminescent agent Substances 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
229960003085 meticillin Drugs 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
JMUHBNWAORSSBD-WKYWBUFDSA-N mifamurtide Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O JMUHBNWAORSSBD-WKYWBUFDSA-N 0.000 description 1
229960005225 mifamurtide Drugs 0.000 description 1
108700007621 mifamurtide Proteins 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
108091005573 modified proteins Proteins 0.000 description 1
102000035118 modified proteins Human genes 0.000 description 1
238000000329 molecular dynamics simulation Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
229940035032 monophosphoryl lipid a Drugs 0.000 description 1
230000004899 motility Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000036438 mutation frequency Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
101150016099 omcA gene Proteins 0.000 description 1
229940126578 oral vaccine Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
108010091212 pepstatin Proteins 0.000 description 1
229950000964 pepstatin Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
150000004633 phorbol derivatives Chemical class 0.000 description 1
239000002644 phorbol ester Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
108010054442 polyalanine Proteins 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
238000011176 pooling Methods 0.000 description 1
230000001124 posttranscriptional effect Effects 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000011085 pressure filtration Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000009465 prokaryotic expression Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
230000020978 protein processing Effects 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
239000000612 proton pump inhibitor Substances 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
229940126583 recombinant protein vaccine Drugs 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000035806 respiratory chain Effects 0.000 description 1
230000028706 ribosome biogenesis Effects 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
235000017709 saponins Nutrition 0.000 description 1
230000009863 secondary prevention Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000010008 shearing Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
229940031439 squalene Drugs 0.000 description 1
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
238000011272 standard treatment Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000002483 superagonistic effect Effects 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical class [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
230000001810 trypsinlike Effects 0.000 description 1
238000010396 two-hybrid screening Methods 0.000 description 1
108010087967 type I signal peptidase Proteins 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
230000009452 underexpressoin Effects 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
210000003934 vacuole Anatomy 0.000 description 1
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
239000000304 virulence factor Substances 0.000 description 1
230000007923 virulence factor Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU25984/97A 1996-03-29 1997-03-27 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof Ceased AU726892B2 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US62581196A	1996-03-29	1996-03-29
US08/625811		1996-03-29
US75873196A	1996-04-02	1996-04-02
US08/758731		1996-04-02
US73690596A	1996-10-25	1996-10-25
US08/736905		1996-10-25
US73885996A	1996-10-28	1996-10-28
US08/738859		1996-10-28
US76131896A	1996-12-06	1996-12-06
US08/761318		1996-12-06
PCT/US1997/005223 WO1997037044A1 (en)	1996-03-29	1997-03-27	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (2)

Publication Number	Publication Date
AU2598497A AU2598497A (en)	1997-10-22
AU726892B2 true AU726892B2 (en)	2000-11-23

Family

ID=27542009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU25984/97A Ceased AU726892B2 (en)	1996-03-29	1997-03-27	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Country Status (18)

Country	Link
EP (1)	EP0901530A1 (is)
JP (1)	JP2000501621A (is)
CN (1)	CN1220703A (is)
AU (1)	AU726892B2 (is)
BR (1)	BR9708456A (is)
CA (1)	CA2248985A1 (is)
CZ (1)	CZ297698A3 (is)
EE (1)	EE9800334A (is)
HU (1)	HUP0100267A3 (is)
ID (1)	ID18542A (is)
IL (1)	IL125808A0 (is)
IS (1)	IS4831A (is)
NO (1)	NO984517L (is)
NZ (1)	NZ332565A (is)
PL (1)	PL329045A1 (is)
SK (1)	SK130598A3 (is)
TR (1)	TR199801939T2 (is)
WO (1)	WO1997037044A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4368944B2 (ja) *	1995-04-21	2009-11-18	シーエスエル、リミテッド	防御用ヘリコバクター抗原
WO1998021225A1 (en) *	1996-11-14	1998-05-22	Merieux Oravax	Helicobacter polypeptides and corresponding polynucleotide molecules
SE9702240D0 (sv) *	1997-06-12	1997-06-12	Astra Ab	Vaccine compositions III
EP2261345A3 (en)	1998-05-01	2012-01-11	Novartis Vaccines and Diagnostics, Inc.	Neisseria meningitidis antigens and compositions
CA2329264A1 (en) *	1998-06-26	2000-01-06	American Cyanamid Company	Novel antigens of helicobacter pylori
DE19847628C2 (de) *	1998-10-15	2000-10-19	Chiron Behring Gmbh & Co	Helicobacter pylori-Impfstoff
GB9825184D0 (en) *	1998-11-17	1999-01-13	Cortecs Uk Ltd	Antigen
EP1173560A1 (en) *	1999-04-30	2002-01-23	Hybrigenics S.A.	Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
SE0001988D0 (sv) *	2000-05-29	2000-05-29	A & Science Invest Ab	Novel polypeptides and use thereof
WO2002040516A2 (de) *	2000-11-15	2002-05-23	Ludwig Deml	DAS HELICOBACTER CYSTEIN RICH PROTEIN A (HcpA) UND SEINE ANWENDUNGEN
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
TW200303919A (en) *	2001-12-05	2003-09-16	Hiroyuki Ohno	Cytotoxic protein and the use
AU2016374289B2 (en) *	2015-12-14	2023-08-03	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Helicobacter pylori vaccines
CN106868024B (zh) *	2017-04-01	2020-03-17	山东新创生物科技有限公司	一种戈氏梭菌特异性pcr检测引物及方法
CN115991745A (zh) *	2022-07-19	2023-04-21	四川大学华西医院	一种幽门螺杆菌重组抗原蛋白TatB及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6327896A (en) *	1995-06-07	1996-12-30	Astra Aktiebolag	Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

1997
- 1997-03-27 JP JP9529649A patent/JP2000501621A/ja active Pending
- 1997-03-27 AU AU25984/97A patent/AU726892B2/en not_active Ceased
- 1997-03-27 SK SK1305-98A patent/SK130598A3/sk unknown
- 1997-03-27 TR TR1998/01939T patent/TR199801939T2/xx unknown
- 1997-03-27 EP EP97917731A patent/EP0901530A1/en not_active Withdrawn
- 1997-03-27 WO PCT/US1997/005223 patent/WO1997037044A1/en not_active Application Discontinuation
- 1997-03-27 HU HU0100267A patent/HUP0100267A3/hu unknown
- 1997-03-27 PL PL97329045A patent/PL329045A1/xx unknown
- 1997-03-27 CA CA002248985A patent/CA2248985A1/en not_active Abandoned
- 1997-03-27 ID IDP971050A patent/ID18542A/id unknown
- 1997-03-27 CZ CZ982976A patent/CZ297698A3/cs unknown
- 1997-03-27 BR BR9708456A patent/BR9708456A/pt not_active IP Right Cessation
- 1997-03-27 EE EE9800334A patent/EE9800334A/xx unknown
- 1997-03-27 CN CN97195113A patent/CN1220703A/zh active Pending
- 1997-03-27 IL IL12580897A patent/IL125808A0/xx unknown
- 1997-03-27 NZ NZ332565A patent/NZ332565A/xx unknown
1998
- 1998-08-21 IS IS4831A patent/IS4831A/is unknown
- 1998-09-28 NO NO984517A patent/NO984517L/no unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6327896A (en) *	1995-06-07	1996-12-30	Astra Aktiebolag	Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

Also Published As

Publication number	Publication date
AU2598497A (en)	1997-10-22
ID18542A (id)	1998-04-16
IL125808A0 (en)	1999-04-11
HUP0100267A3 (en)	2002-09-30
NZ332565A (en)	2000-03-27
TR199801939T2 (xx)	1999-02-22
HUP0100267A2 (hu)	2001-06-28
CN1220703A (zh)	1999-06-23
NO984517D0 (no)	1998-09-28
PL329045A1 (en)	1999-03-01
IS4831A (is)	1998-08-21
NO984517L (no)	1998-11-25
CA2248985A1 (en)	1997-10-09
SK130598A3 (en)	1999-06-11
JP2000501621A (ja)	2000-02-15
EE9800334A (et)	1999-04-15
EP0901530A1 (en)	1999-03-17
BR9708456A (pt)	1999-08-03
CZ297698A3 (cs)	1999-02-17
WO1997037044A1 (en)	1997-10-09

Publication	Publication Date	Title
AU745787B2 (en)	2002-03-28	Enterococcus faecalis polynucleotides and polypeptides
AU2016219667B2 (en)	2018-04-05	Antibacterial phage, phage peptides and methods of use thereof
AU762606B2 (en)	2003-06-26	Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
AU754264B2 (en)	2002-11-07	Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
AU726892B2 (en)	2000-11-23	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
KR100923598B1 (ko)	2009-10-23	스트렙토코커스 피오게네스의 표면 단백질
JPH09322781A (ja)	1997-12-16	Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓポリヌクレオチドおよび配列
AU756010B2 (en)	2003-01-02	Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
AU2015327511B2 (en)	2018-12-06	Biomarkers for rheumatoid arthritis and usage thereof
WO1998058943A1 (en)	1998-12-30	Borrelia burgdorferi polynucleotides and sequences
WO1997037044A9 (en)	1999-01-14	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
KR102191537B1 (ko)	2020-12-16	포유류에서 골 소실을 예방하는 젖산균의 선별 및 이의 용도
RU2673715C2 (ru)	2018-11-29	Вакцина против haemophilus parasuis серологического типа 4
AU734052B2 (en)	2001-05-31	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
AU739641B2 (en)	2001-10-18	Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
EP0977864A2 (en)	2000-02-09	Antigenic composition and method of detection for helicobacter pylori
AU710880B2 (en)	1999-09-30	Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
AU713692B2 (en)	1999-12-09	Nucleic acid and amino acid sequences relating to helicobacter pylori for therapeutics
AU2021240230B2 (en)	2024-04-04	Vaccines and vaccine components for inhibition of microbial cells
AU777190B2 (en)	2004-10-07	Streptococcus pneumoniae polynucleotides and sequences
AU3796099A (en)	1999-08-26	Assays using nucleic acid and amino acid sequences relating to helicobacter pylori
AU1546202A (en)	2002-03-21	Enterococcus faecalis polynucleotides and polypeptides
AU8938601A (en)	2002-01-03	Lyme disease polynucleotides

Legal Events

Date	Code	Title	Description
2001-03-22	FGA	Letters patent sealed or granted (standard patent)
2003-10-30	MK14	Patent ceased section 143(a) (annual fees not paid) or expired